These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27575829)

  • 1. Caveat emptor: Erroneous safety information about opioids in online drug-information compendia.
    Talwar SR; Randhawa AS; Dankiewicz EH; Crudele NT; Haddox JD
    J Opioid Manag; 2016; 12(4):281-8. PubMed ID: 27575829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Collaborative Assessment Among 11 Pharmaceutical Companies of Misinformation in Commonly Used Online Drug Information Compendia.
    Randhawa AS; Babalola O; Henney Z; Miller M; Nelson T; Oza M; Patel C; Randhawa AS; Riley J; Snyder S; So S
    Ann Pharmacother; 2016 May; 50(5):352-9. PubMed ID: 26917822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing a Process to Review Product-Specific Misinformation in Online Drug Information Compendia.
    Talwar SR; Crudele NT; Dankiewicz EH; Randhawa AS; Haddox JD
    Ther Innov Regul Sci; 2015 Mar; 49(2):262-268. PubMed ID: 30222421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
    Olvey EL; Clauschee S; Malone DC
    Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: reliability of compendia methods for off-label oncology indications.
    Abernethy AP; Raman G; Balk EM; Hammond JM; Orlando LA; Wheeler JL; Lau J; McCrory DC
    Ann Intern Med; 2009 Mar; 150(5):336-43. PubMed ID: 19221366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The availability of prescription-only analgesics purchased from the internet in the UK.
    Raine C; Webb DJ; Maxwell SR
    Br J Clin Pharmacol; 2009 Feb; 67(2):250-4. PubMed ID: 19154446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of female patients seeking in-patient treatment for prescription opioid abuse from a tertiary care drug dependence treatment centre from India.
    Dayal P; Balhara YP
    Indian J Med Res; 2016 Jan; 143(1):95-100. PubMed ID: 26997020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical decision support tools: performance of personal digital assistant versus online drug information databases.
    Clauson KA; Polen HH; Marsh WA
    Pharmacotherapy; 2007 Dec; 27(12):1651-8. PubMed ID: 18041886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.
    Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP
    Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Opioid Analgesics: Promoting Patient Safety with Better Patient Education.
    Costello M
    Am J Nurs; 2015 Nov; 115(11):50-6. PubMed ID: 26510070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
    Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
    Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
    Cheatle MD
    Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical decision support tools: analysis of online drug information databases.
    Clauson KA; Marsh WA; Polen HH; Seamon MJ; Ortiz BI
    BMC Med Inform Decis Mak; 2007 Mar; 7():7. PubMed ID: 17346336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety Issues Regarding Prescription Opioids.
    American College of Medical Toxicology
    J Med Toxicol; 2016 Mar; 12(1):142-4. PubMed ID: 26732680
    [No Abstract]   [Full Text] [Related]  

  • 20. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.